Hunan Hansen Pharmaceutical Co Ltd (002412) — Financial Flexibility Index
Hunan Hansen Pharmaceutical Co Ltd (002412) has a Financial Flexibility Index of 0.19x as of September 2025. Free cash flow of CN¥56.32 Million (operating CF CN¥52.51 Million minus capex CN¥3.82 Million) represents 0% of total liabilities (CN¥301.66 Million). Check 002412 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hunan Hansen Pharmaceutical Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Hunan Hansen Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see 002412 cash flow conversion.
Annual Financial Flexibility Index for Hunan Hansen Pharmaceutical Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Hunan Hansen Pharmaceutical Co Ltd. Explore Hunan Hansen Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥256.48 Million | CN¥245.38 Million | CN¥312.15 Million | ▲ +98.4% |
| 2024 | 0.41x | CN¥142.42 Million | CN¥130.78 Million | CN¥343.85 Million | ▼ -14.3% |
| 2023 | 0.48x | CN¥180.42 Million | CN¥160.95 Million | CN¥373.46 Million | ▲ +23.4% |
| 2022 | 0.39x | CN¥155.31 Million | CN¥143.81 Million | CN¥396.81 Million | ▼ -67.3% |
| 2021 | 1.20x | CN¥441.87 Million | CN¥212.54 Million | CN¥368.99 Million | ▲ +20.8% |
| 2020 | 0.99x | CN¥291.27 Million | CN¥162.19 Million | CN¥293.92 Million | ▲ +74.2% |
| 2019 | 0.57x | CN¥200.82 Million | CN¥165.11 Million | CN¥352.93 Million | ▼ -12.2% |
| 2018 | 0.65x | CN¥282.05 Million | CN¥217.52 Million | CN¥435.02 Million | ▲ +98.2% |
| 2017 | 0.33x | CN¥157.38 Million | CN¥107.18 Million | CN¥481.18 Million | ▼ -34.0% |
| 2016 | 0.50x | CN¥206.07 Million | CN¥161.16 Million | CN¥415.88 Million | ▼ -54.9% |
| 2015 | 1.10x | CN¥139.46 Million | CN¥63.57 Million | CN¥126.83 Million | ▲ +48.6% |
| 2014 | 0.74x | CN¥158.80 Million | CN¥85.05 Million | CN¥214.59 Million | ▼ -14.0% |
| 2013 | 0.86x | CN¥184.53 Million | CN¥76.09 Million | CN¥214.46 Million | ▼ -70.0% |
| 2012 | 2.87x | CN¥220.10 Million | CN¥100.23 Million | CN¥76.76 Million | ▲ +71.7% |
| 2011 | 1.67x | CN¥91.74 Million | CN¥53.84 Million | CN¥54.95 Million | ▲ +231.3% |
| 2010 | 0.50x | CN¥24.81 Million | CN¥21.24 Million | CN¥49.23 Million | ▼ -44.6% |
| 2009 | 0.91x | CN¥61.56 Million | CN¥41.02 Million | CN¥67.69 Million | ▲ +63.9% |
| 2008 | 0.55x | CN¥46.98 Million | CN¥33.94 Million | CN¥84.67 Million | ▼ -12.6% |
| 2007 | 0.64x | CN¥54.93 Million | CN¥37.75 Million | CN¥86.49 Million | — |